Orbapin 5 mg+20 mg

ndicated for the treatment of hypertension alone or with other antihypertensive agents, to lower blood pressure. This combination drug is indicated as initial therapy in patients likely to need multiple antihypertensive agents to achieve their blood pressure goals. The decision to use a combination as initial therapy should be individualized and shaped by considerations such as baseline blood pressure, the target goal, and the incremental likelihood of achieving goal with a combination compared to monotherapy. Individual blood pressure goals may vary based upon the patient’s risk.

Orbapin 5 mg+20 mg

  • Product Code: BMO8954152
  • Availability: In Stock
  • BDT 8.03

Tags: Orbapin 5 mg+20 mg